Finjan, Inc. v. Palo Alto Networks, Inc.
- Filed: 11/04/2014
- Case Updated Daily
- Latest Docket Entry: 02/25/2021
January 17, 2021
Finjan, Inc. has just seen another setback in its Northern District of California litigation against Juniper Networks (3:17-cv-05659). On January 9, District Judge William Alsup ruled that much of the NPE’s case against Juniper had been “exceptional” under Octane, due in part to Finjan’s attempt to switch out its infringement theory on the eve of trial—a misstep that led Judge Alsup to throw out its entire damages case. That decision sets the stage for an award of attorney fees against Finjan for its litigation conduct, which Judge Alsup repeatedly decried as having “wasted a great deal of everyone’s time and energy”.
Finjan, which was acquired by Fortress Investment Group LLC last July, filed its lawsuit against Juniper in September 2017 (3:17-cv-05659). The NPE’s complaint accused the company of infringing eight patents—with two later dropped, and another added—through the provision of various antivirus, cloud, and sandboxing products and technologies, including Juniper’s SRX Gateways, Sky ATP, and/or Junos Space Security Director. The following February, Judge Alsup ordered the parties to engage in a “shootout”, a narrowing procedure that he first introduced in early 2017 as a way, in his opinion, to more efficiently get to the merits of a patent case. In a shootout, the plaintiff is required to choose a single patent claim for which it thinks it has the strongest arguments and then to move for summary judgment of infringement and validity as to that sole claim. The defendant, in turn, must pick a “weakest claim” and move for summary judgment of noninfringement and invalidity. If successful, the plaintiff would possibly be awarded a preliminary injunction; and if unsuccessful, the court might “impose a sanctions award on them sua sponte for bringing such a ridiculous claim”.
Two such shootouts occurred over the course of the litigation, and the manner in which Finjan pursued certain key aspects of its case throughout both of those stages led him to conclude in his January 2021 order that the case had been “exceptional”.
The first of the two shootouts were partially resolved in Juniper’s favor in August 2018, when Judge Alsup granted the defendant’s shootout motion as to noninfringement—holding that the company’s SRX Gateway and Sky ATP products do not infringe claim 1 of Finjan’s 6,804,780 patent under the construction of the phrase “performing a hashing function”. Later that month, Judge Alsup then issued an order addressing Finjan’s motion, in which the NPE sought a judgment of infringement and validity as to claim 10 of the 8,677,494 patent. While Judge Alsup partially granted the motion as to infringement for certain claim limitations, he struggled with the application of the parties’ agreed-upon definition of “database” to the identified structures before him, deferring any further, clarifying construction of the term “until the jury is instructed so that the Court will have the benefit of the trial record before construing the term”. He scheduled a trial as to Juniper’s infringement under that construction in December 2018, leading to a verdict of noninfringement as to claim 10 of the ‘494 patent later that month. That verdict, and the case’s other judgments in Juniper’s favor, were later summarily affirmed by the Federal Circuit, before which Finjan had already stipulated to the dismissal with prejudice of its other claims.
Finjan’s pursuit of a flawed damages case both immediately before and during the December 2018 trial led to several rebukes from the court—and Judge Alsup would later describe that conduct, in his January 2021 exceptionality order, as a “fiasco [that] wasted a great deal of everyone’s time and energy”. Key among the underlying missteps was the NPE’s belated attempt to revamp its infringement case: as subsequently recounted by Judge Alsup, “[a]fter discovering its infringement theory covered only a minute portion of Juniper’s revenue base, on the eve of [trial] Finjan flip flopped and came up with a new infringement theory, one which would capture more of Juniper’s products and inflate the target revenue base”. In particular, as previously reported by RPX, Finjan had sought to establish a $7.2M royalty base through the testimony of its damages expert, but Juniper argued that this opinion overreached, in that it counted SRX devices for which the Sky ATP addon had not been installed (as required for infringement). Rather, the company argued, the maximum royalty base—including revenue from the paid version of Sky ATP (a freemium product) and from SRX devices with Sky ATP installed—was just $1.8M. Judge Alsup apparently agreed and excluded the entire damages theory: “Finjan tried to sneak this theory in with its expert-damages report, but we caught it, and the Daubert order excluded that trick”.
Finjan then tried to present a “facts-only damages case” to the jury—an attempt, Judge Alsup underscored, that “utterly failed”. For example, a Finjan executive testified as to what the NPE would have asked from Juniper during negotiations, but Judge Alsup struck that “prejudicial testimony” as “patently irrelevant to the question of the hypothetical royalty that two reasonable parties might have agreed to” (as later summarized; emphasis in original). He then gave Finjan a “stern rebuke” and provided the jury with a limiting instruction. “More broadly”, continued Judge Alsup, “Finjan made no effort at trial to allocate the target revenue base between allegedly infringing product functions and noninfringing functions”, while its facts-only damages case “artificially attempt[ed] to inflate revenue to which it would be entitled” just as its expert had sought to do on the eve of trial. For those reasons, Judge Alsup ultimately struck Finjan’s entire damages case as “woefully inadequate”.
Between its insufficient damages case, and the fact that no injunction was available for the expired ‘494 patent, Judge Alsup lamented in his exceptionality order that the “whole song and dance came to nothing, even before the jury later rejected the merits of the infringement claim”. As a result, he concluded that “[t]he entire assertion of the ‘494 patent thus stood out as exceptional”.
Judge Alsup further faulted Finjan for its litigation conduct during the second shootout, during which Juniper sought and won summary judgment of noninfringement and invalidity of claim 9 of the ‘780 patent, the same patent that it had successfully targeted in the first round. Here, Judge Alsup found that Finjan should have dropped the patent from the case after Juniper’s initial victory, since claim 9 shared the claim limitation that formed the basis for the court’s ruling as to claim 1. Yet the NPE did not; indeed, Judge Alsup noted, Finjan not only kept that claim “in the running” for round two, it “even expanded the scope of accused products”—only to fail to oppose Juniper’s second shootout motion as to the majority of those products. “Just as both parties have a joint duty to frame dispositive issues with good judgment”, explained Judge Alsup, “each party has an individual duty to continually reevaluate the viability of its claims. Finjan shirked its end of both of those duties and again wasted everyone’s time and energy in instigating this motion aspect”. Between those errors and several others related to the second shootout, Judge Alsup found that “Finjan’s assertion of the ‘780 patent stands out as exceptional as well”.
That said, Judge Alsup also declined to find that Finjan’s conduct had been exceptional across the board. For instance, he held that the NPE was within its rights not to accept “claim constructions regarding the ‘154 patent from other tribunals”, countering that the plaintiff “had every right to distinguish and even argue against earlier nonbinding claim constructions by the Patent Trial and Appeal Board and unpublished Federal Circuit memoranda” (emphasis in original). Under the circumstances, Judge Alsup ruled that a fee award in this case should be “limited narrowly to time spent defending against the specific patents tainted by that misconduct”.
Having so ruled, Judge Alsup concluded by reiterating his exceptionality finding as to Finjan’s litigation of the ‘494 and ‘780 patents but declining to award fees just yet. Rather, he ordered Juniper to resubmit its billing records in order to limit them to fees incurred for time spent on those two patents. In a separate order issued that same day, Judge Alsup then proposed the appointment of a special master to oversee the remainder of the fee dispute.
Judge Alsup’s January rulings are the latest of several setbacks suffered by Finjan since the start of last year. In March, the NPE’s Southern District of California case against ESET (3:17-cv-00183) made its way to trial, only to see District Judge Cathy Ann Bencivengo declare a mistrial on the fifth day, with the agreement of counsel, in light of COVID-19. Also delayed was its Northern District of California trial against Cisco (5:17-cv-00072), which in mid-December District Judge Beth Labson Freeman pushed from January 11 to June 4. While that order does not specifically cite the pandemic as the reason, the court had already thrice continued the case as a result of COVID-19. After reportedly stating in April that she was “fairly confident” the trial could be held on its originally scheduled date in June 2020, Judge Freeman continued the trial the following month—moving it to October 19 to allow the court to clear its backlog of criminal cases. Judge Freeman then delayed the case again to November 2 after Cisco raised additional public health concerns, and postponed the case one more time on October 26 to the just-vacated date of January 11.
Also impacted by COVID-19 has been a lawsuit filed against Intel by another Fortress subsidiary, VLSI Technology LLC, in the Western District of Texas (1:19-cv-00977)—where presiding District Judge Alan D. Albright has taken more of a wait-and-see approach to jury trials during the pandemic. Late last year, he moved a trial scheduled in that case from Austin, where the courthouse remains closed, to Waco, in an attempt to proceed with a scheduled January trial. However, the Federal Circuit ruled on December 23 that Judge Albright moved the trial without proper authority and that doing so would require a complete convenience analysis to determine whether the entire case could be transferred to Waco. On December 30, Judge Albright granted plaintiff VLSI’s emergency motion for such a transfer, also announcing that he would push the trial back to mid-February to give Intel time to appeal.
As that appeal proceeds, another issue being litigated is the impact of Fortress’s acquisition of Finjan on the VLSI campaign. Late last year, Intel disclosed that it holds a license to Finjan’s portfolio under a 2012 license agreement that grants to it rights to patents held by Finjan and its “affiliates”. On January 11, Intel filed suit against Fortress in the Delaware Court of Chancery, reportedly seeking a judgment that that Finjan license now also covers all patents held by Fortress and its affiliates, including VLSI, because when Fortress acquired Finjan, they all became “affiliated” under the terms of the agreement.
See here for more on other recent developments in the VLSI campaign.
December 18, 2020
As the COVID-19 pandemic forces California into a second lockdown, courts in two of the state’s federal districts have pushed back scheduled patent trials. On December 14, District Judge James V. Selna of the Central District of California vacated a jury trial previously scheduled for April in litigation between TCL and Ericsson over a standard essential patent (SEP) licensing dispute. Two days later, District Judge Beth Labson Freeman postponed a Northern District of California trial from January to June in litigation filed by NPE Finjan Holdings, Inc. against Cisco following a series of prior continuances entered due to the pandemic. These delays come as other top patent venues contend with the impact of the novel coronavirus: while Chief District Judge Rodney Gilstrap of the Eastern District of Texas recently halted all jury trials before him after an outbreak in a nearby division, District Judge Alan D. Albright of the Western District of Texas has indicated that he may still continue to hold trials.
The Central District of California Delays a Notable SEP Trial
The nation’s most popular patent venues have varied widely in their approach to jury trials during the pandemic, as noted in RPX’s prior coverage, with some districts giving judges the discretion over whether to hold trials in light of local conditions. However, the Central District of California—which includes the state’s four hardest-hit counties, Los Angeles, San Bernardino, Riverside, and Orange—has never greenlit the resumption of jury trials, which have remained suspended with no room for discretion since the court imposed its first COVID-19 restrictions in March. The district has since established a three-stage reopening plan, under which jury trials are not to be resumed until the third stage, based on 14-day infection trends; such trials remain suspended until further notice. Additionally, on December 9—shortly after the state imposed a regional stay-at-home order based on dwindling ICU capacity—Chief District Judge Philip S. Gutierrez activated the district’s Continuity of Operations plan, closing all courthouses to the public except for certain criminal matters and leaving civil trials suspended.
On December 14, Judge Selna cited the pandemic in a two-page order that vacated the April 6 trial date scheduled in TCL v. Ericsson. That decision came at the joint request of the parties, which in a December 2 status joint report cited the “current trajectory of various metrics related to COVID-19, the fact that Orange County moved into the Purple Tier on November 17, 2020, and the Court’s prior comments about the logistical issues associated with conducting a civil trial and summoning a jury panel (e.g., that Orange County be well-established in the Orange Tier prior to summoning a jury, which in turn requires 49 days of lead time)”. (The cited tiers are part of California’s COVID-19 mitigation plan, with purple representing the highest COVID-19 risk level based on a county’s new infection rates.)
That newly delayed trial in the TCL v. Ericsson litigation will be the second time that the SEP issues at play come before the district court, following a notable trip back from the Federal Circuit. Judge Selna had previously issued a bench trial order establishing that certain licensing offers made by Ericsson to TCL had purportedly not been fair, reasonable, and non-discriminatory (FRAND), further setting the terms of a FRAND license—just the fourth US ruling in which a court has determined a FRAND rate for a SEP portfolio. Significantly, the court also denied Ericsson’s request for a jury trial on the claims decided. However, in December 2019, the Federal Circuit overturned that decision, ruling that the lower court had deprived Ericsson of its constitutional right to a jury trial by deciding a key license term from the bench.
In setting a new trial as a result of that opinion, Judge Selna indicated to the parties in April 2020 that under the Federal Circuit’s ruling, the “key error” was failing to “afford a jury trial on the release payment” (the license term previously decided from the bench) because that payment is best characterized as “patent damages”—i.e., damages for past patent infringement. Such a determination is both “intertwined” with the determination that Ericsson’s offers to TCL were not FRAND and “inextricably tied” to the determination of a forward royalty rate. As a result, Judge Selna held, the entire prior judgment must fall and a jury must be seated.
More recently, in August, the Federal Circuit further established that the question of whether a patent is essential to a standard should also be determined by a jury—upholding an infringement ruling for a subsidiary of IP Bridge, Inc. against TCL.
For more on the appeal ruling in TCL v. Ericsson, see “California FRAND Ruling Deprived Ericsson of Right to Jury Trial, Holds Federal Circuit” (December 2019).
Finjan’s Trial Against Cisco Gets Delayed Following Spring Setback in Another Case
Meanwhile, the Northern District of California’s penultimate coronavirus order, dated September 16, cleared the way for civil and criminal jury trials, to be conducted “in accordance with the logistical considerations necessitated by the Court’s safety protocols”, following prior suspensions of all such trials. However, as a result of state and local shelter-in-place orders, the court subsequently updated its website to state that “the court will suspend all in-person, in-court proceedings at all Northern District of California courthouses. This suspension will remain in effect through January 10, 2021, with a planned resumption of some limited proceedings, if possible, on January 11, 2021”.
The trial continuance that Judge Freeman entered in the Finjan v. Cisco litigation pushes back a trial previously set to begin on January 11 to June 4. While the order does not specifically cite COVID-19 as the reason, the court had already thrice delayed the case as a result of the pandemic. After reportedly stating in April that she was “fairly confident” the trial could be held on its originally scheduled date in June 2020, Judge Freeman continued the trial the following month—moving it to October 19 to allow the court to clear its backlog of criminal cases. Judge Freeman then delayed the case again to November 2 after Cisco raised additional public health concerns, and postponed the case one more time on October 26 to the just-vacated date of January 11. This Finjan lawsuit was the second to see a trial undercut by COVID-19: the NPE’s Southern District of California case against ESET (3:17-cv-00183) made its way to trial in March, but District Judge Cathy Ann Bencivengo declared a mistrial on the fifth day, with the agreement of counsel, in light of the pandemic.
Texas Judges Have Begun to Diverge on Jury Trials
Worsening COVID-19 infection rates have also led formerly bullish courts to walk back earlier efforts to proceed with patent trials. Among the most notable examples is Judge Rodney Gilstrap of the Eastern District of Texas, who resumed jury trials this past August, holding the nation’s first patent jury trial since the start of the pandemic—resulting in one notable verdict—after coronavirus infection rates in and around his district began to drop. However, as the pandemic’s second wave began to worsen, a trial in a breach of contract case in a nearby division under District Judge Amos L. Mazzant III ended in a mistrial after a COVID-19 outbreak struck the participants—with 15 people, including multiple jurors, members of the plaintiff’s and the defendant’s legal team, and court staff, getting infected. In light of that outbreak and rising case numbers nearby, Judge Gilstrap took the significant step of halting all jury trials before him. Judge Gilstrap stated that he was doing so “reluctantly” but asserted that he had no alternative—arguing that the face-to-face aspect of in-person trials is essential for due process. Judge Mazzant, for his part, has since cancelled a retrial previously scheduled for January 25 in the aforementioned breach of contract case, providing no reason for doing so.
In contrast to Judge Gilstrap, District Judge Alan D. Albright of the Western District of Texas appears to be moving forward with his next trial—at least, for now. In late November, in litigation filed by Fortress Investment Group LLC subsidiary VLSI Technology LLC (1:19-cv-00977), defendant Intel asked to push back a trial scheduled for January 11 to March, observing that “[c]ase and death numbers in McLennan County and in Texas now mirror or are approaching those from July 2020, when the Waco Division was closed to jury trials” and further warning that “those numbers are only expected to continue to rise after the holidays”. A hearing was held on Intel’s requested continuance on December 15; while the minutes for that hearing are unavailable, Judge Albright’s calendar still lists the trial as scheduled on January 11—suggesting that Judge Albright did not grant the motion (or at least, has not yet decided it). That hearing comes shortly after Judge Albright, speaking at a recent IP conference, reportedly expressed confidence about his court’s ability to safely conduct IP trials, following what he described as a positive experience conducting a patent trial this past October.
For details on that October trial, see “Roku Wins Noninfringement Verdict in Judge Albright’s First Patent Trial” (October 2020).
June 14, 2020
On June 10, publicly traded NPE Finjan Holdings, Inc. revealed that it has agreed to be acquired by global investment manager Fortress Investment Group LLC in an all-cash deal valued at $43.9M. The press release announcing the transaction stated that Finjan “will maintain its brand and business model post-transaction”, continuing to license and enforce the anti-malware portfolio that the NPE has been asserting in litigation since 2006.
May 31, 2020
The Northern District of California has dismissed Finjan Holdings, Inc.’s case against Check Point Software Technologies with prejudice, following a joint stipulation filed by the parties on May 27 that disclosed a settlement. The dismissal comes as some of Finjan’s other cases have seen trial dates get pushed back as a result of the COVID-19 pandemic—most recently, the NPE’s pending trial against Cisco, which earlier in the week was delayed until October 19, as reflected in a May 28 SEC filing from Finjan.
March 17, 2020
Finjan, Inc., a subsidiary of publicly traded Finjan Holdings, Inc., has added yet another case to the long-running litigation campaign begun back in 2006, suing Singapore Telecommunications (Trustwave) (1:20-cv-00371). The plaintiff asserts just one of the nearly two dozen patents that have been at issue throughout this campaign, the lot of them generally related to anti-malware technology. Infringement allegations target the provision of anti-malware and security software, including the Trustwave Secure Email Gateway and the Trustwave Secure Web Gateway. The new complaint comes as District Judge Cathy Ann Bencivengo declared a mistrial—“based upon the current state of extraordinary circumstances due to the Coronavirus/COVID-19 Pandemic”—in a Southern District of California case brought against ESET.
January 24, 2020
Finjan Holdings, Inc. announced on January 23 a patent license and settlement agreement with BitDefender, resolving all disputes between the companies, including a lawsuit filed against BitDefender in 2017. According to an SEC filing, under the agreement, BitDefender will pay Finjan $3.8M and receive a license to each of Finjan’s patent portfolios.
May 3, 2019
Finjan Holdings, Inc. announced on May 1 that it has entered into a patent license and settlement agreement with Zscaler, resolving all claims between them, including litigation in the Northern District of California. According to an 8-K filed by Finjan, Zscaler has paid the company $7.25M and (along with certain affiliates) will receive “a license to, among others, the patents of Finjan, Finjan Mobile, Inc., and Finjan Blue, Inc.” The agreement was apparently reached amid claim construction briefing ahead of a May 28 Markman hearing. It follows Finjan’s string of settlements last year with Symantec (for up to $110M), Carbon Black (for $3.9M), and Trend Micro ($13.4M).
March 15, 2019
District Judge William Alsup of the Northern District of California has denied a post-trial motion by Finjan, Inc., rejecting its attempt to overturn a December noninfringement verdict for Juniper Networks and denying its request for a new trial (3:17-cv-05659). In that verdict, the jury found that Juniper had not infringed a single claim from a Finjan anti-malware patent after struggling with the application of a key claim term; in a March 11 order, Judge Alsup held that the jury had not erred by reaching that verdict. The denial of Finjan’s post-trial motions is just the latest of multiple setbacks for the NPE in this lawsuit, following significant difficulties with its damages case—including Judge Alsup’s holding that Finjan had overinflated its asserted royalty base and his decision to exclude the entire testimony of its damages expert. The single-claim December trial stemmed from the case’s first “patent shootout”, an unorthodox procedure designed by Judge Alsup to more efficiently get to the merits of a patent case by forcing the parties to litigate their best arguments first.
Jury Returns Noninfringement Verdict for Juniper in Finjan Suit Amidst Uncertainty over Definition of “Schema”December 28, 2018
A California jury has issued a verdict of noninfringement for Juniper Networks in litigation brought by Finjan, Inc., finding that the defendant’s SRX and Sky ATP products do not infringe a single claim from one of the NPE’s anti-malware patents (3:17-cv-05659). The issue of infringement turned on whether the accused products contain a “database”, based on a stipulated definition of that claim term that includes the word “schema”, as itself defined in the IBM Dictionary of Computing (“IBM Dictionary”). The jury appears to have struggled with the definition of “schema”, asking the court on the last day of trial if it could refer to the IBM Dictionary definition of that term—a request that District Judge William Alsup denied because the dictionary had not been entered into evidence. The trial did not ultimately address the issue of patent subject matter eligibility, as the court had previously indicated; while the parties had proposed competing jury instructions and verdict forms on Section 101 at Judge Alsup’s apparent insistence, the parties stipulated shortly before trial that the court would decide the issue. No such ruling on patent eligibility has yet issued.
November 30, 2018
Patent subject matter eligibility has traditionally been regarded primarily as a matter of law, with facts playing a supporting role for courts asked to analyze patents under Alice and its progeny. However, through its Berkheimer and Aatrix decisions this past February, the Federal Circuit elevated that role for facts. The court ruled that a defendant cannot win early dismissal under Section 101 where a patent-holder raises sufficient issues of fact as to whether the challenged claims contain an inventive concept. This shift raised the possibility that patent eligibility might become an issue not typically decided until trial—yet a jury has not weighed in on Section 101 since the issuance of Alice, and did so only once before that. This month could see that change: in an imminent trial between Finjan, Inc. and Juniper Networks, a jury will be asked to determine if one of the NPE’s antimalware patents is invalid under Section 101. Proposed jury instructions filed on November 28 show that the parties sharply diverge as to how the jury should be instructed on that issue.
September 21, 2018
Another Finjan Holdings, Inc. patent has survived a validity challenge. On September 19, the Federal Circuit upheld a March 2017 decision in an inter partes review (IPR) filed by Palo Alto Networks, finding that a malware detection patent held by the publicly traded NPE is not invalid as obvious. The decision affirmed the PTAB’s holding that the asserted combinations of prior art did not disclose a key claim limitation related to the processing of data received over a network. It comes shortly after Finjan, buoyed by recent settlements in its ongoing litigation campaign, reported $82.3M in revenue for the first half of 2018, an increase of more than 200% over the same period last year.
April 10, 2018
Cybersecurity company Carbon Black filed for an IPO on April 9—the same day that Finjan Holdings, Inc. announced that it had entered into a patent license and settlement agreement with the company. According to an 8-K filed by Finjan, Carbon Black has agreed to pay Finjan $3.9M in license fees; further, upon acquisition of Carbon Black, or acquisitions by the company, additional one-time payments, equal to 8% of the gross revenue of certain qualifying products for the four concluded quarters preceding the acquisition, will be due to Finjan. The agreement resolves a patent infringement suit filed by Finjan against Carbon Black on March 21. It also follows a string of multi-million dollar settlements in Finjan’s anti-malware campaign, including one signed in Q1 with Symantec for up to $110M. Finjan reports having licensed its portfolio to more than 20 companies to date, generating over $350M in licensing fees; it has also indicated to investors that more such deals are in the works.
March 1, 2018
Finjan Holdings, Inc. announced on March 1 that it had entered into an agreement with Symantec and its Blue Coat Systems subsidiary that resolves all pending claims between the parties. According to an 8-K filed by Finjan, Symantec will pay $65M for a patent license, paying additional license fees of up to $45M upon Symantec’s acquisition of certain entities within four years from the agreement’s effective date. This deal follows a year in which Finjan disclosed having signed five multi-million dollar settlements in its anti-malware campaign. It also comes on the heels of the Federal Circuit’s trimming of a $39.5M Finjan trial verdict against Blue Coat.
January 2018 PTAB Activity Spans Several Market Sectors and Includes Challenges Against Frequent LitigantsFebruary 2, 2018
The Patent Trial and Appeal Board (PTAB) saw petitions for inter partes review (IPR) filed in large campaigns affecting a variety of market sectors in January, including the automotive campaign waged by Intellectual Ventures LLC; frequent plaintiff Realtime Data LLC’s long-running data compression and media streaming campaign; the USB device charging campaign brought by Fundamental Innovation Systems International LLC; and the mobile device campaign run by IPA Technologies Inc., a subsidiary of publicly traded Quarterhill Inc. The Board instituted trial in January for petitions against Realtime Data and in the sprawling, 12-year anti-malware campaign still being litigated by publicly traded Finjan Holdings, Inc. The PTAB also issued final decisions in January in IPRs against Realtime Data; ChriMar Systems, Inc.; and IP Bridge, Inc.
Federal Circuit Trims $39.5M Finjan Verdict Against Blue Coat Systems, Prompting Mistrial in Second CaseJanuary 11, 2018
The Federal Circuit has overturned part of a $39.5M verdict issued in August 2015 against Symantec subsidiary Blue Coat Systems in a lawsuit brought by Finjan, Inc., a subsidiary of publicly traded Finjan Holdings, Inc. (5:13-cv-03999). In a January 10 opinion, the Federal Circuit reversed a finding of infringement as to one of the asserted patents, thus lowering the verdict by $7.8M, and remanded as to the $24M damages award for another patent, ruling that Finjan had provided an erroneous damages calculation at trial (2016-2520). The issuance of that decision led District Judge Beth Labson Freeman to grant Blue Coat’s motion for a mistrial in the second of two trials in Finjan’s other case against the company, which had started just two days before (5:15-cv-03295).
January 7, 2018
The Patent Trial and Appeal Board (PTAB) remained at the center of a heated public debate over the issue of tribal sovereign immunity in December 2017. Motions to dismiss filed by the Saint Regis Mohawk Tribe in IPRs against several Allergan patents—acquired by the tribe and licensed back to their original owner to shield them through sovereign immunity—remain pending as the PTAB considers a wave of amicus briefs filed on both sides of the issue. The Board has since denied the tribe’s motion for an oral hearing on discovery related to alleged bias held by the USPTO and its leadership, and that bias’s effect on the selection of judges for the tribe’s case. Meanwhile, among the petitions for inter partes review (IPR) filed in December was one brought by Apple against MEC Resources, LLC, an entity owned by another Native American tribe, which took over an existing lawsuit asserting the challenged patent against Apple in the fall. Also in December, the Board issued institution decisions in petitions against Iridescent Networks, Inc.; Lone Star Silicon Innovations LLC; and publicly traded Quarterhill Inc.; while an IPR against Packet Intelligence LLC ended in an adverse judgment after petitioner Sandvine prevailed in a November trial.
January 5, 2018
Amid claim construction briefing ahead of a January 18 Markman hearing, Finjan Holdings, Inc. and FireEye announced that they had entered into confidential patent license agreements, resolving litigation between the companies. According to Finjan’s December 29 press release, FireEye has agreed to pay Finjan a “one-time net settlement amount of approximately $12.5 million payable in cash”. The deal includes cross-licenses for an unidentified group of patents as well as for “any issued patents and any patent applications filed on or before the first anniversary of the date” of the agreements.
December 9, 2017
Zscaler (3:17-cv-06946) is the latest defendant to be added to Finjan, Inc.’s sole litigation campaign, which last month saw a partial infringement verdict against Symantec subsidiary Blue Coat Systems. Finjan has accused Zscaler of infringing four anti-malware patents—including one that was tried against Blue Coat in November—through provision of various products and services related to Internet access and cloud security. This latest complaint brings Finjan’s defendant count close to 20, with some targeted companies (i.e., Blue Coat, ESET) sued by the NPE in both the US and Germany.
California Jury Issues Partial Infringement Verdict Against Blue Coat Systems in Finjan’s International Anti-Malware CampaignNovember 21, 2017
A jury in the Northern District of California has found that Symantec subsidiary Blue Coat Systems infringed two out of six anti-malware patents at issue in a suit brought by Finjan, Inc., following a three-week trial (5:15-cv-03295). In a verdict issued on November 20, the jury declined to find that Blue Coat’s infringement of those two patents had been willful and found that the defendant had not infringed any patents under the doctrine of equivalents, also awarding $490K in damages. The jury was unable to reach a unanimous verdict for another two of the asserted patents.
October 7, 2017
In September 2017, the Patent Trial and Appeal Board (PTAB) saw more than ten petitions filed in NPE campaigns involving networking and related technologies such as cybersecurity, including those waged by publicly traded Finjan Holdings, Inc.; prolific private litigant Realtime Data LLC; and Oyster Optics, LLC. Trial was instituted in September for an inter partes review (IPR) against Finjan and in IPRs against other frequent plaintiffs, including MyMail, Ltd. and Sound View Innovations, LLC. The Board issued final decisions in two covered business method (CBM) reviews against Uniloc Corporation Pty. Limited, the first AIA reviews against the NPE to reach final decisions since March 2016, and only the fourth to date. The PTAB also issued final decisions in IPRs against publicly traded Document Security Systems, Inc. as well as Acceleration Bay, LLC; Mobile Telecommunications Technologies, LLC; and Personalized Media Communications, LLC; among other NPEs.
October 1, 2017
Finjan, Inc., a subsidiary of publicly traded Finjan Holdings, Inc., has added a third new suit in its sole litigation campaign, filing suit against Juniper Networks (5:17-cv-05659) last week after suing SonicWall and Bitdefender separately in August. Each of the eight patents at issue in the newest complaint broadly concerns anti-malware technology and has been asserted against at least the prior defendants in the campaign, which has been active since 2006. Finjan targets the provision of various antivirus, cloud, and sandboxing technologies, including through Juniper’s SRX Gateways, Sky ATP, and/or Junos Space Security Director.
September 1, 2017
The Patent Trial and Appeal Board (PTAB) saw the number of petitions for AIA review filed against NPEs drop by more than half in August 2017, down to 30 petitions from 68 in July. Petitions were brought in August against publicly traded Finjan Holdings, Inc., inventor Leigh M. Rothschild, and a mix of prolific private litigants, including Blackbird Tech LLC, Realtime Data LLC, and Uniloc Corporation Pty. Limited. Meanwhile, the Board instituted trial in August for petitions against a variety of entities, including the California Institute of Technology and publicly traded Quarterhill Inc. as well as IP Bridge, Inc.; Realtime Data; and Uniloc. The PTAB also issued final decisions throughout August in campaigns waged by publicly traded Acacia Research Corporation; Advanced Touchscreen and Gesture Technologies, LLC; Elm 3DS Innovations LLC; and Rosetta-Wireless Corporation.
August 19, 2017
The sole litigation campaign of Finjan Holdings, Inc. continues to grow as it approaches trial dates in three of its ongoing cases. On August 16, the company’s Finjan, Inc. subsidiary filed suit against Bitdefender (4:17-cv-04790), alleging infringement of four patents through provision of various antivirus, cloud, and sandboxing technologies. The Bitdefender case comes on the heels of another new suit in Finjan’s campaign, filed against SonicWall (5:17-cv-04467) on August 4, and follows Finjan CEO Phil Hartstein’s recent remarks to investors about his company’s plans to accelerate its licensing and enforcement efforts.
July PTAB Activity Includes Petitions Against Repeat Players and Decisions in Networking and Semiconductor CampaignsAugust 4, 2017
The Patent Trial and Appeal Board (PTAB) continued to see petitions for AIA review filed against prolific litigants in July, including a wave of petitions against Uniloc Corporation Pty. Limited across four separate campaigns, with petitions also brought against General Patent Corporation, Intellectual Ventures LLC (IV), Papst Licensing GmbH & Company Kg, and Quarterhill Inc. Meanwhile, throughout July, the Board instituted trial for inter partes reviews (IPRs) filed in semiconductor campaigns waged by Harvard University and the California Institute of Technology, with trial also instituted in campaigns related to network data compression (Realtime Data LLC), servers and data management (IV), and anti-malware technology (Finjan Holdings, Inc.). Final decisions issued by the Board in July included one that cancelled claims from a patent that has been asserted by Rothschild Connected Devices Innovations, LLC, an NPE controlled by inventor Leigh M. Rothschild, against more than 60 defendants.
April 28, 2017
Publicly traded NPE Finjan Holdings, Inc. has announced a product partnership with German security software provider Avira, the same day that the two companies entered into an apparently separate $4.9M patent license agreement. Under the terms of the partnership, formed on April 21 and revealed in an April 26 press release, Finjan subsidiary Finjan Mobile, Inc. will integrate Avira’s Virtual Private Network (VPN) platform into its own VitalSecurity mobile browser suite. This deal is the first of its kind for Finjan, which continues to wage a decade-long litigation campaign that has seen multiple trials and settlements, and comes as other publicly traded NPEs have signaled that they intend to diversify their activities and move beyond patent assertion alone.
In a Form 8-K filed on April 26, Finjan disclosed that it had agreed, as part of a cross-license agreement, to pay Avira $3.9M in licensing fees, paid in twelve quarterly installments of $325K, for access to its VPN technology along with technical support. Although the assets covered by that license agreement have not been disclosed, the agreement is apparently distinct from the other confidential license agreement executed on April 21, which was disclosed in a separate 8-K filed on April 25. Under the latter transaction, Avira will receive a license to “the Finjan patent portfolio” in exchange for a $4.9M license fee, with $2.3M to be paid within ten days of April 21, another $1.3M on or before January 31, 2018, and the final $1.3M on or before January 31, 2019.
Finjan’s efforts to bolster its product offerings follow a series of pivots away from patent assertion by other publicly traded NPEs, some of which have variously expanded their active product operations, reduced their reliance on patent assertion, and even exited the patent market altogether. In February, Tessera Holding Corporation changed its name to Xperi Corporation as part of a broader realignment, with the company now increasingly focused on research and development as well as product licensing. That rebranding and strategic shift began last year and led to the company’s $955M acquisition of DTS, a company specializing in digital surround sound and audio technology, in December 2016. (For more information on Xperi’s new business strategy and the impact of the DTS acquisition on its 2016 financial results, see “InterDigital’s Q4 2016 Revenue Surges as Rebranded Tessera Reports Loss After DTS Acquisition” (February 2017).)
Additionally, on April 17, Wi-LAN Inc. (WiLAN) announced a dramatic restructuring of its business model under which the company will de-emphasize patent licensing. By June of this year, WiLAN intends to change its name to Quarterhill, Inc. and will operate its patent licensing business as a subsidiary, while pursuing a new growth strategy focused on the acquisition of companies in the Industrial Internet of Things (IIoT) sector. Meanwhile, Acacia Research Corporation has announced a strategic refocus on “viable IP” after having filed markedly less litigation in 2016 than in years past. The first step in that refocus is Acacia’s $20M investment in Veritone, a cloud-based artificial intelligence company, with a further $30M in funding contingent on Veritone’s performance. Finally, certain NPEs have exited the patent assertion business altogether. In June 2016, Unwired Planet sold its patent portfolio to Leslie Ware’s Optis UP and has since changed its name to Great Elm Capital Corp., with the company now focused on business development. (For more details on these latest developments for WiLAN, Acacia, and other publicly traded NPEs, see “Amid Announcement of a New Growth Strategy, Questions Remain About WiLAN’s Threat to Operating Companies” (April 2017).)
While Finjan’s latest actions also indicate a possible shift away from patent assertion, the litigation campaign waged by subsidiary Finjan, Inc. remains active. On March 30, the NPE entered into a confidential settlement agreement with campaign defendant Sophos (3:14-cv-01197), roughly two weeks after the company was denied a new trial in the wake of a September 2016 infringement verdict. Meanwhile, the NPE filed a pair of new cases in January against Cisco (3:17-cv-00072) along with Avast and subsidiary AVG (4:17-cv-00283). On March 27, the Avast/AVG case was dismissed after the parties reached a reported, confidential agreement, while Cisco filed a motion to dismiss the case against it on April 26, alleging pleading deficiencies.
In addition, cases remain active against Symantec (3:14-cv-02998) and subsidiary Blue Coat Systems (5:15-cv-03295), as well as suits against FireEye (4:13-cv-03133) and Palo Alto Networks (4:14-cv-04908). The Palo Alto Networks action has been stayed since May 2016 pending the outcome of multiple inter partes reviews (IPRs) against the patents-in-suit. Between mid-March and early April, the Patent Trial and Appeal Board issued final decisions in eleven of those IPRs, cancelling claims from a single Finjan patent (8,677,494) in an IPR filed by Symantec (IPR2015-01892, joined with another filed by Blue Coat, IPR2016-00890) and another filed by Palo Alto Networks (IPR2016-00159, joined with another Blue Coat IPR, IPR2016-01174) but declining to cancel any claims from three of the other challenged patents (7,647,633; 8,141,154; 8,225,408). Additionally, the FireEye case was stayed in June 2014 pending the re-examination of two of the patents-in-suit (the 7,058,822 and ‘633 patents). Meanwhile, a claim construction order was issued in early February in the Symantec case, while a Markman hearing scheduled for February 10 in the Blue Coat action was cancelled after the parties resolved their outstanding disputes regarding claim construction.
For more information about recent developments in the Finjan campaign, as well as a history of earlier litigation, see “California Judge Declines to Grant Retrial in Finjan Suit Against Sophos” (March 2017).
April 7, 2017
The Patent Trial and Appeal Board (PTAB) continued to see the filing of petitions for inter partes review (IPR) against publicly traded NPEs in March 2017, including Acacia Research Corporation; Finjan Holdings, Inc.; Pendrell Corporation; TiVo Corporation (formerly known as Rovi Corporation); and Wi-LAN Inc. (WiLAN). A variety of prolific, privately held NPEs were also targeted for IPR throughout March, including Blackbird Tech LLC, General Patent Corporation, IP Edge LLC, Realtime Data LLC, and Papst Licensing GmbH & Company Kg, along with several inventors and inventor-controlled NPEs and an assortment of other plaintiffs.
March 17, 2017
A California judge has declined to grant a new trial in Finjan, Inc.’s case against Sophos (3:14-cv-01197). In a ruling issued on March 14, District Judge William H. Orrick denied the company’s motion for a new trial as well as a motion for attorney fees filed by Finjan, ruling that the case was not exceptional under Octane.
February 1, 2017
Godo Kaisha IP Bridge 1 (IP Bridge 1), a subsidiary of Japanese patent monetization firm IP Bridge, Inc., filed an affirmative case asserting two former Panasonic patents (7,265,450; 7,893,501) against Xilinx (2:17-cv-00100) in the Eastern District of Texas on January 31, the expiration date of a standstill agreement entered into by the two parties to facilitate licensing discussions. The next day, Xilinx filed a complaint (3:17-cv-00509) in the Northern District of California that seeks declaratory judgments that the company does not infringe any valid claim from twelve former Panasonic patents (6,483,151; 6,492,665; 6,653,731; 6,873,052; 6,969,915; 7,053,461; 7,417,289; 7,525,189; 7,564,102; 7,728,439; 8,203,186; 8,278,763) held by IP Bridge 1. All fourteen patents at issue in the two cases generally relate to various aspects of semiconductor fabrication. The day after expiration of a similar standstill agreement (July 1, 2016), Finjan, Inc. (3:16-cv-03731) and ESET (3:16-cv-01704) filed competing complaints in the Northern and Southern Districts of California, respectively; Finjan won that battle but appears to have lost the war, as last week the Northern District granted a motion to change venue, transferring the case before it down to the Southern District (3:17-cv-00183).
January 20, 2017
Finjan Holdings, Inc. has added Avast and subsidiary AVG (4:17-cv-00283) to its decade-long litigation campaign, accusing the companies of infringing six anti-malware patents (6,154,844; 7,930,299; 7,975,305; 8,079,086; 8,141,154; 8,677,494) through the provision of AVG security software and services. This latest complaint comes less than two weeks after another suit filed by Finjan against Cisco (3:17-cv-00072), which is alleged to infringe the ‘844, ‘154, and ‘494 patents along with two others (6,804,780; 7,647,633) through similar products.
January 6, 2017
Finjan Holdings, Inc. has added Cisco (3:17-cv-00072) to its long-running litigation campaign, accusing the company of infringing five anti-malware patents 6,154,844; 6,804,780; 7,647,633; 8,141,154; 8,677,494). At issue are various types of Cisco security software and services, including its Advanced Malware Protection (AMP) and AMP Threat Grid, Cisco Collective Security Intelligence (CCSI), and Cisco Outbreak Filters technologies, as well as the threat detection services offered by Cisco’s Talos Security Intelligence and Research Group.
December 9, 2016
Finjan Holdings, Inc. has added F5 Networks to its decade-long litigation campaign, accusing the company of infringing four anti-malware patents (6,965,968; 7,975,305; 8,141,154; 8,677,494) through its security software (3:16-cv-06955). The suit follows a potential setback in the NPE’s suit against Sophos, which on November 28 requested a new trial in the wake of a $15M infringement verdict issued against the company in September.
November 3, 2016
District Judge William Orrick has entered a judgment against Sophos, affirming a September jury verdict that the company directly infringed five Finjan, Inc. anti-malware patents (3:14-cv-01197). The October 31 judgment orders Sophos to pay $15M in damages and follows a failed attempt by Blue Coat Systems to overturn a jury’s $39.5M verdict against the company in a another suit brought by Finjan. For RPX’s past coverage of the verdicts against Sophos and Blue Coat Systems, see here and here, respectively.
October 18, 2016
Finjan, Inc., a subsidiary of publicly traded Finjan Holdings, Inc., has filed a third patent infringement suit against Blue Coat Systems, this time in Germany. Finjan’s latest suit, filed on October 14 in the German District Court of Dusseldorf, asserts a European patent (EP 0 965 094) generally related to anti-malware technology–the same patent the NPE asserted in a July suit in Germany against ESET. This week’s filing follows a failed attempt by Blue Coat to overturn a jury’s $39.5M verdict against the company in another suit brought by Finjan in the US. It also comes less than a month after a California jury awarded Finjan $15M in damages in a trial against Sophos.
September 23, 2016
A California jury has issued a verdict against Sophos, finding on September 21 that the company’s security software infringes five anti-malware patents (6,154,844; 6,804,780; 7,613,926; 8,141,154; 8,677,494) asserted by Finjan, Inc. (3:14-cv-01197). However, while the jury awarded Finjan $15M in damages, it also determined that Sophos had not willfully infringed the patents-in-suit. The jury’s decision follows the July denial of a motion by campaign co-defendant Blue Coat Systems to overturn a $39.5M verdict against the company in another suit brought by Finjan (5:13-cv-03999).
Blue Coat Systems Fails to Overturn $39.5M Jury Award in Finjan Case, but Avoids Enhanced Damages and FeesJuly 22, 2016
Blue Coat Systems has lost its attempt to escape a $39.5M jury award in an infringement suit brought by Finjan, Inc. (5:13-cv-03999) over six anti-malware patents (6,154,844; 6,804,780; 6,965,968; 7,058,822; 7,418,731; 7,647,633). In an order issued on July 18, District Judge Beth Labson Freeman denied Blue Coat’s motion for a new trial and its renewed motion for judgment as a matter of law (RJMOL). The company had argued in its retrial motion that improperly admitted evidence concerning settlement and licensing agreements between Finjan and other defendants, as well as testimony regarding Blue Coat’s total product revenues during the infringement period, had resulted in undue prejudice to the jury. Judge Freeman rejected these arguments, holding that the evidence had not been highly prejudicial. The court then denied Blue Coat’s RJMOL motion, ruling that the jury’s August 2015 verdict had been supported by sufficient evidence with regard to both damages and infringement, and declined to revisit an earlier bench trial order. Although these rulings left standing the original $39.5M jury award, Judge Freeman also denied Finjan’s request for a further $120M in enhanced damages under the more relaxed standard set by the Supreme Court’s recent decision in Halo/Stryker. In addition, the court denied Finjan’s motion for attorney fees, ruling that the case was not exceptional under Octane, but granted the NPE’s motion for pre- and post-judgment interest.
June 10, 2016
Proofpoint has reached a $10.9M settlement with Finjan, Inc., ending the NPE’s infringement suit shortly before the parties were due to begin trial (3:13-cv-05808). On June 7, 2016, District Judge Haywood S. Gilliam dismissed the case with prejudice following a joint stipulation filed by Finjan, Proofpoint, and the latter’s co-defendant and subsidiary Armorize Technologies. Their confidential settlement resolves a three-year lawsuit launched by Finjan in December 2013, one of the NPE’s most recent filings in a litigation campaign that has been active for over a decade. This multimillion-dollar payment is the second made in Finjan’s long-running campaign over the past year, which saw a $39.5M infringement verdict issued against Blue Coat Systems in August 2015.
January 21, 2016
On January 14, 2016, the Patent Trial and Appeal Board (PTAB) rejected six petitions for inter partes review (IPR) filed by Symantec, in which the company had challenged five Finjan, Inc. patents (7,757,289; 8,141,154; 7,930,299; 8,015,182; 7,756,996). Symantec had sought to invalidate various claims in the challenged patents under both §102 and §103, arguing that prior art rendered the ‘182 patent obvious and that the ‘289, ‘154, ‘299, and ‘996 patents were both obvious and anticipated. However, for each petition, the Board ruled that Symantec failed to show that it had a reasonable likelihood of prevailing with any of its asserted grounds for invalidity, and thus had not met the threshold for institution.
November 6, 2014
Palo Alto Networks is the newest defendant in Finjan, Inc.’s ongoing campaign. Ten patents are asserted in the suit, which accuses Palo Alto Networks’s security products of infringement (6,804,780, 6,965,968, 7,058,822, 7,418,731, 7,613,918, 7,613,926, 7,647,633, 8,141,154, 8,225,408, 8,677,494). The patents-in-suit relate to computer and network security systems, and all of them have been asserted in Finjan’s previous litigations. Palo Alto Networks’s security and firewall products are accused of infringing the asserted patents.